Sleep Aids in the US

Sleep Aids in the US
Maintaining the trend from 2022, sleep aids is expected to continue to face decline in retail current value and volume terms in 2023, further offsetting the strong growth surge seen in the category during the peak pandemic years of 2020 and 2021, when consumers dealt with intense stress-related insomnia. While the soft performance for sleep aids in the past two years can be interpreted as a slow return to its pre-pandemic equilibrium, consumers are still experiencing sleep anxieties due to worri...

Euromonitor International's Sleep Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.